PMDA drug package insert
ノベルジン錠25mg
PMDA Prescription drug · ノーベルファーマ株式会社 · package insert Apr 6, 2026
Key facts
| Brand names | ノベルジン錠25mg, ノベルジン錠50mg, ノベルジン顆粒5% |
|---|---|
| Nonproprietary names | 酢酸亜鉛水和物 |
| Companies | 製造販売元／ノーベルファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ウィルソン病治療剤（銅吸収阻害剤） 低亜鉛血症治療剤 |
| Therapeutic category codes | 873929 |
| YJ codes | 3929007F1029, 3929007F2025, 3929007D1028 |
| Approval numbers | 22600AMX01299000, 22600AMX01300000, 30300AMX00013000 |
| Package insert edition | 第6版 |
| Package insert date | Apr 6, 2026 |
| PMDA document key | 620095_3929007F1029_2 |
| PMDA company code | 620095 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: